Share this post on:

Product Name :
Tropifexor

Search keywords :
Tropifexor

drugId :
null

Target Vo:
Bile acid receptor FXR

Target Vo Short Name :
FXR

Moa_Name:
Bile acid receptor FXR agonists

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Novartis Pharma Ag

Active Company_Name :
Novartis Pharma Ag

Active Indication_Name:
Liver Diseases

In Active Indication_Name:
Metabolic Dysfunction-Associated Steatotic Liver Disease

Termination Status :

China Termination Status :
Phase 2 Clinical

Highest Status:
Phase 1 Clinical

China Highest Status:
Discontinued

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Efruxifermin Autophagy
Ferritin Heavy Chain Rabbit mAb Purity
AmCyan Tag Antibody (YA864): AmCyan Tag Antibody (YA864) is an unconjugated, approximately 55 kDa, mouse-derived, anti-AmCyan Tag (YA864) monoclonal antibody. AmCyan Tag Antibody (YA864) can be used for: WB expriments in species-independent background without labeling.

Share this post on:

Author: Interleukin Related